Related Experiment Video

Updated: Aug 14, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Statins in rheumatology

Martin Soubrier1, Christian Roux

  • 1Rheumatology Department, G. Montpied Hospital, Place H. Dunant, BP 69, 63003 Clermont-Ferrand, France. msoubrier@chu-clermontferrand.fr

Joint Bone Spine
|November 23, 2005
PubMed

Insights

Statins effectively reduce cardiovascular risks. While their benefits for rheumatoid arthritis (RA) and osteoporosis are suggested, further research is needed. Patients with RA or lupus should monitor lipids and consider statins if dyslipidemia is present.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Pharmacology

Background:

  • Statins are primary treatments for lipid disorders, reducing cardiovascular disease (CVD) risk.
  • Increased CVD morbidity and mortality are observed in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
  • Potential benefits of statins in RA and osteoporosis are suggested but not yet confirmed.

Purpose of the Study:

  • To evaluate the role of statins in managing cardiovascular risks associated with RA and SLE.
  • To summarize current recommendations for lipid management in patients with inflammatory autoimmune diseases.

Main Methods:

  • Review of existing literature on statin efficacy in lipid disorders.
  • Analysis of cardiovascular risk factors in patients with RA and SLE.
  • Assessment of current guidelines for dyslipidemia treatment.

Main Results:

  • Statins are proven effective in primary and secondary cardiovascular prevention.
  • Patients with RA and SLE have elevated cardiovascular risks.
  • Current recommendations advise lipid assays and statin therapy for dyslipidemia in these patient groups.

Conclusions:

  • Statins are crucial for managing dyslipidemia and reducing cardiovascular events.
  • Cardiovascular health monitoring and appropriate statin use are recommended for RA and SLE patients.
  • Further studies are warranted to confirm statin benefits in non-lipid related conditions like RA.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...